These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30450518)

  • 1. New Experimental Facts on the Influence of Secondary Immunodeficiency on the Morphology and Biological Activity of Colorectal Tumor.
    Struchko GY; Merkulova LM; Moskvichev EV; Kostrova OY; Mikhailova MN
    Bull Exp Biol Med; 2018 Nov; 166(1):75-79. PubMed ID: 30450518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
    Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
    Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.
    Yu HG; Yu LL; Yang Y; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
    Oncology; 2003; 65(1):37-45. PubMed ID: 12837981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
    Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
    Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
    Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V
    Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
    Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
    Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
    Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
    J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of rat colon cells to cancer and vaccination with anti-p53 polyclonal antibodies.
    Tendler Y; Ben-Hur H; Gurevich P; Berman V; Sandler B; Nyska A; Zion H; Zinder O; Zusman I
    Anticancer Res; 1997; 17(6D):4653-7. PubMed ID: 9494584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiogenesis in colorectal carcinomas using VEGF and BCl2: An IHC study.
    Vasala A; Nair H; Rao TS; Murthy SS; Tagore R; Ahmed F
    Ann Diagn Pathol; 2017 Dec; 31():41-44. PubMed ID: 29146057
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological and immunohistochemical characteristics of the thymus during chemical carcinogenesis induced by 1,2-dimethylhydrazine administration].
    Struchko GY; Merkulova LM; Moskvichov YV
    Morfologiia; 2014; 146(5):35-9. PubMed ID: 25823287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.